On November 18th, Cure MAPT FTD co-founder Linde Jacobs spoke movingly at the University of California at San Francisco Memory and Aging Center Lecture Series on genetic FTD. Her presentation centered on how the disease has impacted her grandmother, mother, sisters and herself.
Introduced by Dr. Claire Clelland, one of our Scientific Advisory Board members, the physicians clearly found inspiration by her story. One of the most exciting moments of the event? Dr. Clelland mentioned that FTD might be one of the first neurodegenerative diseases to be cured with genetic therapies.
See highlighted screenshots from the event below:
To learn more about Linde's story, a familiar story to many who develop MAPT, watch the following video from a talk given at Global Tau 2024
Share
.png)
